Abstract
Clinical genetics services continue to expand into diverse medical specialties. An ever-increasing number of non-genetics providers are independently ordering genetic tests, interpreting results, and at times, making diagnoses leading to patient care recommendations. Non-genetics healthcare providers can help increase patient access to these services, but a potential pitfall occurs when these providers either do not have adequate expertise with genetic variant interpretation or do not have access to multi-disciplinary teams including genetic counselors or clinical geneticists for advanced review. In the cardiology setting, variant misinterpretation can lead to misattribution of disease risk, unnecessary treatments or management, and potentially adverse psychosocial and financial effects. To address this, case reports and series are needed to highlight variant misinterpretation and misdiagnoses, including discussion of possible solutions and best practices for avoidance. This report details a child previously diagnosed with long QT syndrome type 4 by chromosomal microarray who was then subsequently managed for this disease by cardiac providers with insufficient expertise to critically review and question the genetic testing results. The patient was eventually referred to a pediatric electrophysiology team as part of a larger multidisciplinary cardiovascular genetics program, composed of specialist genetic counselors, cardiologists, and clinical geneticists. Advanced review and clinical evaluation raised concern about the initial genetic testing result and diagnosis. Complementary testing with a different modality to confirm or disconfirm the chromosome microarray result was performed, providing evidence that the original result reflected analytic error in the laboratory as well as interpretive error by the clinical geneticist and that the patient was misdiagnosed, and treated over the course of years, for long QT syndrome. This case shows the value of multidisciplinary teams caring for patients with inherited cardiovascular diseases.
Similar content being viewed by others
References
Arscott, P., Caleshu, C., Kotzer, K., Kreykes, S., Kruisselbrink, T., Orland, K., Rigelsky, C., Smith, E., Spoonamore, K., Larsen Haidle, J., Marvin, M., Ackerman, M. J., Hadi, A., Mani, A., Ommen, S., & Cherny, S. (2016). A case for inclusion of genetic counselors in cardiac care. Cardiology in Review, 24(2), 49–55.
Bland, A., Harrington, E. A., Dunn, K., Pariani, M., Platt, J. C. K., Grove, M. E., & Caleshu, C. (2017). Clinically impactful differences in variant interpretation between clinicians and testing laboratories: A single-center experience. Genetics in Medicine. https://doi.org/10.1038/gim.2017-212.
Caleshu, C., Day, S., Rehm, H. L., & Baxter, S. (2010). Use and interpretation of genetic tests in cardiovascular genetics. Heart, 96(20), 1669–1675.
Carroll, J. C., Makuzawa, T., Manca, D. P., Sopcak, N., Permaul, J. A., O’Brien, M. A., et al. (2016). Primary care providers’ experiences with and perceptions of personalized genomic medicine. Canadian Family Physician, 62(10), e626–e635.
Ducharme J. (2017) ‘I’m permanently damaged.’ woman sues after she says doctors unnecessarily removed her breasts and uterus. Time (Online). Accessed 6 March 2018: http://time.com/4994961/breast-cancer-uterus-surgery/.
Gella, A., Segura, M., Durany, N., Pfuhlmann, B., Stöber, G., & Gawlik, M. (2011). Is Ankyrin a genetic risk factor for psychiatric phenotypes? BMC psychiatry, 11, 103. https://doi.org/10.1186/1471-244X-11-103.
Giudicessi, J. R., & Ackerman, M. J. (2013). Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Translational Research, 161(1), 1–14.
Hashemi, S. M., Hund, T. J., & Mohler, P. J. (2007). Cardiac ankyrins in health and disease. Journal of Molecular and Cellular Cardiology, 47(2), 203–209.
Helm, B. M., Freeze, S. L., Spoonamore, K. G., Ware, S. M., Ayers, M. D., & Kean, A. C. (2018). The genetic counselor in the pediatric arrhythmia clinic: Review and assessment of services. Journal of Genetic Counseling, 27(3), 558–564.
Hershberger, R. E. (2008). Cardiovascular genetic medicine: Evolving concepts, rationale, and implementation. Journal of Cardiovascular Translational Research, 1, 137–143.
Hintsa, T., Puttonen, S., Toivonen, L., Kontula, K., Swan, H., & Keltikangas-Järvinen, J. (2010). A history of stressful life events, prolonged mental stress and arrhythmic events in inherited long QT syndrome. Heart, 96(16), 1281–1286.
Horner, J. M., Horner, M. M., & Ackerman, M. J. (2011). The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm, 8(11), 1698–1704.
Ingles, J., Yeates, L., O’Brien, L., McGaughran, J., Scuffham, P. A., Atherton, J., & Semsarian, C. (2012). Genetic testing for inherited heart diseases: Longitudinal impact on health-related quality of life. Genetics in Medicine, 14, 749–752.
Johnson, J. N., & Ackerman, M. J. (2009). QTc: How long is too long? British Journal of Sports Medicine, 43(9), 657–662.
Kearney, H. M., Thorland, E. C., Brown, K. K., Quintera-Rivera, F., South, S. T., & Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. (2011). American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in Medicine, 13(7), 680–685.
Kohane, I. S., Masys, D. R., & Altman, R. B. (2006). The incidentalome: A threat to genomic medicine. JAMA, 296, 121–125.
Malovini, A., Bellazzi, R., Napolitano, C., & Guffanti, G. (2016). Multivariate methods for genetic variants selection and risk prediction in cardiovascular diseases. Frontiers in Cardiovascular Medicine, 3, 17. https://doi.org/10.3389/fcvm.2016.00017.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 769–764.
Mohler, P. J., Healy, J. A., Xue, H., Puca, A. A., Kline, C. F., Allingham, R. R., et al. (2007). Ankyrin-B syndrome: Enhanced cardiac function balanced by risk of cardiac death and premature senescence. PLoS One, 10(e1051), 1–10.
Moscarello, T., Murray, B., Reuter, C. M., & Demo, E. (2018). Direct-to-consumer raw genetic data and third-party interpretation services: More burden than bargain? Genetics in Medicine. https://doi.org/10.1038/s41436-018-0097-2.
Obeyesekere, M. N., Klein, G. J., Modi, S., Leong-Sit, P., Gula, L. J., Yee, R., Skanes, A. C., & Krahn, A. D. (2011). How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia. Circulation. Arrhythmia and Electrophysiology, 4, 958–964.
Pasic, M. D., Samaan, S., & Yousef, G. M. (2013). Genomic medicine: New frontiers and new challenges. Clinical Chemistry, 59(1), 158–167.
Priori, S. G., Wilde, A. M., Horie, M., Cho, Y., Behr, E. R., Berul, C., et al. (2013). HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm, 10(12), 1932–1963.
Rehm, H. L. (2017). Evolving health care through personal genomics. Nature Reviews. Genetics, 18(4), 259–267.
Reuter, C., Grove, M. E., Orland, K., Spoonamore, K., & Caleshu, C. (2017). Clinical cardiovascular genetic counselors take a leading role in team-based variant classification. Journal of Genetic Counseling, 27, 751–760. https://doi.org/10.1007/s10897-017-0175-7.
Richards, S., Nazneen, A., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., et al. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405–423.
Riley, J. D., Procop, G. W., Kottke-Marchant, K., Wyllie, R., & Lacbawan, F. L. (2015). Improving molecular genetic test utilization through order restriction, test review, and guidance. The Journal of Molecular Diagnostics, 17(3), 225–229.
Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., Miller, K. J., Frazier, J. A., Silverstein, I., Picker, J., Weissman, L., Raffalli, P., Jeste, S., Demmer, L. A., Peters, H. K., Brewster, S. J., Kowalczyk, S. J., Rosen-Sheidley, B., McGowan, C., Duda, A. W., Lincoln, S. A., Lowe, K. R., Schonwald, A., Robbins, M., Hisama, F., Wolff, R., Becker, R., Nasir, R., Urion, D. K., Milunsky, J. M., Rappaport, L., Gusella, J. F., Walsh, C. A., Wu, B. L., Miller, D. T., & on behalf of the Autism Consortium Clinical Genetics/DNA Diagnostics Collaboration. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727–e735.
Sherman, J., Tester, D. J., & Ackerman, M. J. (2005). Targeted mutational analysis of Ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects. Heart Rhythm, 2(11), 1218–1223.
Sturm, A. C., & Hershberger, R. E. (2013). Genetic testing in cardiovascular medicine: Current landscape and future horizons. Current Opinion in Cardiology, 28(3), 317–325.
Tandy-Connor, S., Guiltinan, J., Krempely, K., LaDuca, H., Reineke, P., Gutierrez, S., & Davis, B. T. (2018). False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care. Genetics in Medicine. https://doi.org/10.1038/gim.2018.38.
Zhang, C., Kutyifa, V., Moss, A. J., McNitt, S., Zareba, W., & Kaufman, E. S. (2015). Long-QT syndrome and therapy for attention deficit/hyperactivity disorder. Journal of Cardiovascular Electrophysiology, 26(10), 1039–1044.
Acknowledgements
This publication was made possible by the Indiana University School of Medicine Strategic Research Initiative. We thank Lindsey Elmore with her assistance during the IRB review process. Parts of this case report were presented in oral abstract form at the 2017 Scientific Sessions of the Heart Rhythm Society (Chicago, IL).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Benjamin M. Helm, Mark D. Ayers, and Adam C. Kean declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the local medical ethics boards of the Indiana University School of Medicine. This case report was deemed exempt from IRB review (IRB no. 1806166474) and did not require informed consent.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Helm, B.M., Ayers, M.D. & Kean, A.C. All Along the Watchtower: a Case of Long QT Syndrome Misdiagnosis Secondary to Genetic Testing Misinterpretation. J Genet Counsel 27, 1515–1522 (2018). https://doi.org/10.1007/s10897-018-0287-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-018-0287-8